Bank of America’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Sell
140,936
-39,159
-22% -$4.01M ﹤0.01% 2815
2026
Q1
$19.7M Buy
180,095
+50,497
+39% +$4.81M ﹤0.01% 2402
2025
Q4
$10.5M Buy
129,598
+4,405
+4% +$379K ﹤0.01% 2812
2025
Q3
$11M Buy
125,193
+9,930
+9% +$887K ﹤0.01% 3215
2025
Q2
$9.57M Buy
115,263
+26,966
+31% +$2.25M ﹤0.01% 3262
2025
Q1
$7.41M Buy
88,297
+26,545
+43% +$2.47M ﹤0.01% 3442
2024
Q4
$5.69M Buy
61,752
+15,250
+33% +$1.47M ﹤0.01% 3461
2024
Q3
$4.32M Sell
46,502
-13,789
-23% -$1.19M ﹤0.01% 3875
2024
Q2
$4.96M Buy
60,291
+17,010
+39% +$1.25M ﹤0.01% 3629
2024
Q1
$2.87M Buy
43,281
+3,336
+8% +$206K ﹤0.01% 4147
2023
Q4
$2.27M Buy
39,945
+27,565
+223% +$1.44M ﹤0.01% 4285
2023
Q3
$674K Sell
12,380
-14,029
-53% -$831K ﹤0.01% 5096
2023
Q2
$1.78M Buy
26,409
+1,812
+7% +$111K ﹤0.01% 4319
2023
Q1
$1.27M Sell
24,597
-1,665
-6% -$80.8K ﹤0.01% 4747
2022
Q4
$1.21M Buy
26,262
+5,396
+26% +$253K ﹤0.01% 4684
2022
Q3
$1.06M Buy
20,866
+1,778
+9% +$88.8K ﹤0.01% 4852
2022
Q2
$870K Sell
19,088
-7,136
-27% -$319K ﹤0.01% 5029
2022
Q1
$1.22M Sell
26,224
-8,697
-25% -$389K ﹤0.01% 5050
2021
Q4
$1.75M Buy
34,921
+800
+2% +$41.4K ﹤0.01% 4693
2021
Q3
$1.81M Buy
34,121
+13,620
+66% +$767K ﹤0.01% 4535
2021
Q2
$1.25M Sell
20,501
-24,454
-54% -$1.3M ﹤0.01% 4717
2021
Q1
$2.19M Buy
44,955
+23,110
+106% +$1.08M ﹤0.01% 4181
2020
Q4
$885K Buy
21,845
+4,002
+22% +$143K ﹤0.01% 4608
2020
Q3
$580K Sell
17,843
-26,857
-60% -$806K ﹤0.01% 4593
2020
Q2
$1.18M Buy
44,700
+3,881
+10% +$101K ﹤0.01% 4010
2020
Q1
$1.02M Buy
40,819
+12,428
+44% +$384K ﹤0.01% 4001
2019
Q4
$1.02M Sell
28,391
-1,493
-5% -$51.5K ﹤0.01% 4497
2019
Q3
$1.02M Buy
29,884
+11,025
+58% +$352K ﹤0.01% 4527
2019
Q2
$528K Buy
18,859
+4,341
+30% +$121K ﹤0.01% 5025
2019
Q1
$450K Sell
14,518
-8,513
-37% -$227K ﹤0.01% 5074
2018
Q4
$544K Buy
23,031
+14,243
+162% +$389K ﹤0.01% 4874
2018
Q3
$340K Sell
8,788
-17,928
-67% -$646K ﹤0.01% 5196
2018
Q2
$895K Sell
26,716
-37,330
-58% -$1.33M ﹤0.01% 4538
2018
Q1
$2.32M Sell
64,046
-18,281
-22% -$633K ﹤0.01% 3768
2017
Q4
$2.62M Sell
82,327
-64,670
-44% -$2.22M ﹤0.01% 3717
2017
Q3
$5.5M Sell
146,997
-138,903
-49% -$4.73M ﹤0.01% 3098
2017
Q2
$8.93M Buy
285,900
+92,249
+48% +$2.66M ﹤0.01% 2486
2017
Q1
$4.77M Buy
193,651
+536
+0.3% +$12.6K ﹤0.01% 3070
2016
Q4
$4.89M Buy
193,115
+1,295
+0.7% +$28.7K ﹤0.01% 2941
2016
Q3
$3.81M Buy
191,820
+38,444
+25% +$672K ﹤0.01% 3083
2016
Q2
$2.19M Buy
153,376
+1,404
+0.9% +$21.5K ﹤0.01% 3557
2016
Q1
$2.36M Buy
151,972
+118,094
+349% +$1.69M ﹤0.01% 3429
2015
Q4
$584K Buy
33,878
+33,863
+225,753% +$490K ﹤0.01% 4715
2015
Q3
$0 Sell
15
-227
-94% -$2.91K ﹤0.01% 7317
2015
Q2
$3K Buy
+242
New +$2.38K ﹤0.01% 6966
2014
Q2
Sell
-340
Closed -$3K 8127
2014
Q1
$3K Sell
340
-9
-3% -$72 ﹤0.01% 7466
2013
Q4
$3K Buy
+349
New +$2.7K ﹤0.01% 7568
2013
Q3
Sell
-6
Closed 7964
2013
Q2
$0 Buy
+6
New +$38 ﹤0.01% 7730

Other funds holding LMAT

Bank of America's LMAT Position: Q2 2026 in Review

Bank of America reduced its LeMaitre Vascular (LMAT) stake by 22% in Q2 2026, selling an estimated $4.01M and leaving 140,936 shares worth $13.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2815.

Bank of America first reported a position in LMAT in Q2 2013 and has held it in 48 quarters since. The position peaked at $19.7M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Bank of America held 140,936 shares of LeMaitre Vascular worth $13.5M as of Q2 2026.
  • Bank of America sold 39,159 LeMaitre Vascular shares in Q2 2026, an estimated $4.01M.
  • LeMaitre Vascular made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #2815 holding.
  • Bank of America first reported a position in LeMaitre Vascular in Q2 2013 and has held it in 48 quarters since.
  • Bank of America's LeMaitre Vascular position peaked at $19.7M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.